Settle claims for treatment in make-shift COVID-19 hospitals: IRDAI to insurers
"...in order to ensure that the costs of treatment of COVID-19 are covered as per the terms and conditions of policy contract, a make-shift or temporary hospital permitted by Central/State government shall be regarded as a hospital or network provider and insurers shall settle the claims (as per the specified norms)," the Insurance Regulatory and Development Authority of India (IRDAI) said in a circular.
New Delhi - In a relief to policy holders, regulator Irdai on Thursday asked general and health insurers to settle claims for treatment at make-shift or temporary hospitals set up for COVID-19 patients.
In view of the increasing number of coronavirus cases, several state governments have set up make-shift or temporary hospitals. The number of coronavirus cases is rising rapidly and is expected to soon cross 1 million mark in the country.
"...in order to ensure that the costs of treatment of COVID-19 are covered as per the terms and conditions of policy contract, a make-shift or temporary hospital permitted by Central/State government shall be regarded as a hospital or network provider and insurers shall settle the claims (as per the specified norms)," the Insurance Regulatory and Development Authority of India (IRDAI) said in a circular.
The regulator said when a policyholder, who is diagnosed as COVID-19 positive, is admitted into any such make-shift or temporary hospital on the advice of a medical practitioner or appropriate government authorities, notwithstanding the definition of hospital specified in the terms and conditions of policy contract, the treatment costs shall be settled by insurers.
It further added that where any network provider has set up any such make-shift or temporary hospital, such make-shift or temporary hospital shall be regarded as the extension of the network provider and cashless facility shall be made available.
The regulator also directed general and health insurers to expedite settlement of all such claims in accordance to the applicable regulatory framework.
The insurers have also been advised to incorporate the above norms in claim guidelines and inform all the third-party administrators (TPAs) immediately.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.